You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

ABIRPRED

Cancer Type: Genitourinary, Prostate      Intent: Palliative
Regimen Category: Evidence-Informed
Funding:
Exceptional Access Program
    abiraterone - Metastatic castrate-resistant prostate cancer, with specific criteria
ODB - General Benefit
    prednisone

You might also be interested in